Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;23(7):776-777.
doi: 10.1016/S1473-3099(23)00287-6. Epub 2023 May 5.

Prevention of long COVID: progress and challenges

Affiliations

Prevention of long COVID: progress and challenges

Ziyad Al-Aly. Lancet Infect Dis. 2023 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

I report receiving consultation fees from Gilead Sciences and Tonix pharmaceuticals. I also report consulting (uncompensated) for Pfizer; I have no other relationships or activities that could appear to have influenced the submitted work. This Comment was funded by the US Department of Veterans Affairs (to ZAA). The contents do not represent the views of the US Department of Veterans Affairs or the US government.

References

    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133–146. - PMC - PubMed
    1. Xie Y, Choi T, Al-Aly Z. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med. 2023 doi: 10.1001/jamainternmed.2023.0743. published online March 23. - DOI - PMC - PubMed
    1. Xie Y, Choi T, Al-Aly Z. Molnupiravir and risk of post-acute sequelae of COVID-19: cohort study. BMJ. 2023;381 - PMC - PubMed
    1. Uehara T, Yotsuyanagi H, Ohmagari N, et al. Ensitrelvir for mild-to-moderate COVID-19: phase 3 part of phase 2/3 study. https://www.shionogi.com/content/dam/shionogi/global/investors/ir-librar...
    1. Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28:2398–2405. - PMC - PubMed

Publication types